Add BrightSurf on Google Email

First detection of an artemisinin-resistant malaria parasite contracted in Africa

Scientists have detected an artemisinin-resistant malaria parasite originating from West Africa for the first time in Africa, posing a significant threat to malaria control efforts. The finding confirms that the parasite carries a new mutation in the Kelch13 gene, which is the primary driver of resistance in Southeast Asia.

SourceKing Abdullah University of Science & Technology (KAUST)·JournalNew England Journal of Medicine·DateFeb 22, 2017

Experimental malaria vaccine offers durable protection against many strains in NIH trial

A Phase 1 clinical trial found that the PfSPZ Vaccine protected 64% of healthy adults from a different malaria strain, while also inducing durable T cell responses. The vaccine showed cross-protection against multiple strains, providing hope for an effective malaria vaccine.

SourceNIH/National Institute of Allergy and Infectious Diseases·JournalProceedings of the National Academy of Sciences·DateFeb 21, 2017

Modern housing associated with reduced malaria risk in sub-Saharan Africa

A study published in PLOS Medicine found that modern houses with metal roofs and finished walls are associated with a reduced risk of malaria in children under age 5. The researchers analyzed data from 29 surveys in 21 African countries and found a significant correlation between improved housing conditions and lower malaria rates.

SourcePLOS·JournalPLOS Medicine·DateFeb 21, 2017

Study: Experimental malaria vaccine plus chloroquine protects against controlled infection

An experimental malaria vaccine strategy, PfSPZ-CVac, combined with antimalarial medication protected all nine clinical trial volunteers given three high-dose vaccinations. The vaccine induced a response from T cells and identified 22 malaria parasite proteins that could be the targets of protective immune responses.

Why malaria mosquitoes like people with malaria

Researchers discovered that malaria parasites produce HMBPP, which stimulates red blood cells to release carbon dioxide and volatile compounds attracting malaria mosquitoes. The parasite uses this system to transfer from one host to another, making it harder to control the spread of malaria.

SourceStockholm University·JournalScience·DateFeb 9, 2017

Scientists opened a new chapter in the study of malaria mosquitoes

Scientists have successfully cultivated a new species of malaria mosquito in the laboratory, allowing for more accurate investigation of their physiology and ability to transfer the disease. The study also found that the species has an expanded habitat range across Eurasia, with populations declining in some areas due to climate change.

SourceNational Research Tomsk State University·JournalJournal of Vector Ecology·DateDec 29, 2016

The Lancet Infectious Diseases: Scientists identify genetic markers of resistance to frontline malaria drug that could help control outbreaks

Researchers have identified genetic markers associated with resistance to the antimalarial drug piperaquine, which could help track and contain outbreaks in Southeast Asia. The findings suggest that amplification of plasmepsin genes is linked to piperaquine resistance and may be used to identify patients at risk of treatment failure.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·DateNov 3, 2016